Hyox Systems (UK) introduces oxygen therapy unit:
This article was originally published in Clinica
Executive Summary
Hyox Systems (UK) has introduced HTU3 its new hyperbaric oxygen therapy unit. The chamber is pressurised with air by an integral compressor, and has a "unique gas supply control panel", the company claims. Pressurisation rate is fixed, reaching a maximum 2 kg/cm(2) in approximately 20 minutes, and the operator can stop and start the process manually. Also featured are electrical auto-shutdown and a mechanical override pressure relief valve. Oxygen concentration within the chamber is continually monitored and displayed, and an audio-visual alert is activated at a preset 25%. There are two preset depressurisation rates, and a failsafe valve which can exhaust the chamber to atmospheric pressure in less than two minutes. The HTU3 also has a two-way communication system, and a separate channel to allow external stereo sound sources to be fed into the chamber.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.